http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180055745-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_02ad4c9403364a2277dc906d5bc5642e |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-00032 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-00031 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C11D3-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-0082 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K10-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N63-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C11D3-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C11D3-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K20-195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N63-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C11D3-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K10-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L2-00 |
| filingDate | 2017-11-16^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a203e2e900d475c5634b8cfdd532eee3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfbb81429999a67212a3a011d63f6a76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67a1be0166da9f8efab5c06f45a961b2 |
| publicationDate | 2018-05-25^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20180055745-A |
| titleOfInvention | Novel Salmonella Enteritidis specific bacteriophage and antibacterial composition comprising the same |
| abstract | The present invention relates to a novel bacteriophage KFS-SE having a killing effect specific to Salmonella enteritidis, a pharmaceutical composition for preventing or treating infectious diseases caused by Salmonella enteritidis including the bacteriophage, an antibiotic composition, , A feed, a disinfectant or detergent, and a method for preventing or treating an infectious disease caused by Salmonella enteritidis comprising administering the bacteriophage to an individual. The method for the prevention or treatment of infectious diseases caused by Salmonella enteritidis using the bacteriophage KFS-SE of the present invention is more effective than the conventional antibiotics such as Salmonella enteritidis alone and has excellent lytic activity and physicochemical environment It has the advantage of being strong. In addition, the bacteriophage KFS-SE of the present invention has an advantage of being able to solve the problem of antibiotic-resistant bacteria caused by misuse of antibiotics, the problem of remaining antibiotics in food, and the problem of a wide host range. Therefore, the bacteriophage KFS-SE of the present invention can be used in various fields in the field of prevention or treatment of infectious diseases caused by Salmonella enteritidis, composition for antibiosis, composition for feed addition, feed, disinfectant or detergent, It has the effect of contributing to the improvement of competitiveness and the public health. |
| priorityDate | 2016-11-17^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 149 of 149.